scAtria single-cell spatial atlas resource

NSCLC_38242124 · IMC / Imaging Mass Cytometry

NSCLC_38242124 · NSCLC_38242124__IMC

IMC / Imaging Mass Cytometry Spatial proteomics Curated Tiered

Interaction Propensity

Download spatial tables

Interaction Propensity (Tier 1)

2,069 ready
Sample Organ Disease state Cells Strongest directed pair ?Tier 1 from-label to to-label pair with the largest departure from neutral propensity among enriched/depleted contacts. Direction Propensity FDR
NSCLC_38242124__IMC__175_B2,3 Lung Primary cancer 4,979 Tumor/Malignant -> Tumor/Malignant Enriched 5.48 1.06e-2
NSCLC_38242124__IMC__175_B2,4 Lung Primary cancer 3,269 Tumor/Malignant -> Tumor/Malignant Enriched 5.29 1.76e-2
NSCLC_38242124__IMC__175_B2,5 Lung Primary cancer 3,929 Tumor/Malignant -> Tumor/Malignant Enriched 5.43 1.22e-2
NSCLC_38242124__IMC__175_B2,6 Lung Primary cancer 3,446 Tumor/Malignant -> Tumor/Malignant Enriched 4.36 9.90e-3
NSCLC_38242124__IMC__175_B2,7 Lung Primary cancer 3,595 Tumor/Malignant -> Tumor/Malignant Enriched 5.69 2.26e-2
NSCLC_38242124__IMC__175_B2,8 Lung Primary cancer 2,386 Tumor/Malignant -> Tumor/Malignant Enriched 4.03 1.06e-2
NSCLC_38242124__IMC__175_B2,9 Lung Primary cancer 4,016 Tumor/Malignant -> Tumor/Malignant Enriched 5.04 9.90e-3
NSCLC_38242124__IMC__175_B3,1 Lung Primary cancer 3,874 Tumor/Malignant -> Tumor/Malignant Enriched 5.08 1.06e-2
NSCLC_38242124__IMC__175_B3,10 Lung Primary cancer 1,896 Tumor/Malignant -> Tumor/Malignant Enriched 3.19 1.22e-2
NSCLC_38242124__IMC__175_B3,11 Lung Primary cancer 2,889 Tumor/Malignant -> Tumor/Malignant Enriched 5.35 2.26e-2
NSCLC_38242124__IMC__175_B3,12 Lung Primary cancer 4,330 Tumor/Malignant -> Tumor/Malignant Enriched 5.56 1.13e-2
NSCLC_38242124__IMC__175_B3,13 Lung Primary cancer 912 Tumor/Malignant -> Tumor/Malignant Enriched 5.05 1.98e-2
NSCLC_38242124__IMC__175_B3,15 Lung Primary cancer 2,727 Stromal -> Stromal Enriched 3.38 1.58e-2
NSCLC_38242124__IMC__175_B3,16 Lung Primary cancer 4,456 Tumor/Malignant -> Tumor/Malignant Enriched 4.25 1.06e-2
NSCLC_38242124__IMC__175_B3,17 Lung Primary cancer 2,318 Tumor/Malignant -> Tumor/Malignant Enriched 4.30 1.44e-2
NSCLC_38242124__IMC__175_B3,2 Lung Primary cancer 3,084 Tumor/Malignant -> Tumor/Malignant Enriched 3.66 1.13e-2
NSCLC_38242124__IMC__175_B3,3 Lung Primary cancer 4,329 Tumor/Malignant -> Tumor/Malignant Enriched 5.51 1.58e-2
NSCLC_38242124__IMC__175_B3,4 Lung Primary cancer 1,576 Tumor/Malignant -> Tumor/Malignant Enriched 4.70 1.13e-2
NSCLC_38242124__IMC__175_B3,5 Lung Primary cancer 3,081 Tumor/Malignant -> Tumor/Malignant Enriched 5.52 1.06e-2
NSCLC_38242124__IMC__175_B3,6 Lung Primary cancer 3,664 Tumor/Malignant -> Tumor/Malignant Enriched 4.24 1.06e-2

Interaction Propensity (Tier 2)

2,069 ready
Sample Organ Disease state Cells Strongest directed pair ?Tier 1 from-label to to-label pair with the largest departure from neutral propensity among enriched/depleted contacts. Direction Propensity FDR
NSCLC_38242124__IMC__175_B2,3 Lung Primary cancer 4,979 Tumor/Malignant -> Tumor/Malignant Enriched 5.48 1.46e-2
NSCLC_38242124__IMC__175_B2,4 Lung Primary cancer 3,269 Tumor/Malignant -> Tumor/Malignant Enriched 5.29 2.25e-2
NSCLC_38242124__IMC__175_B2,5 Lung Primary cancer 3,929 Tumor/Malignant -> Tumor/Malignant Enriched 5.43 1.90e-2
NSCLC_38242124__IMC__175_B2,6 Lung Primary cancer 3,446 Tumor/Malignant -> Tumor/Malignant Enriched 4.36 1.13e-2
NSCLC_38242124__IMC__175_B2,7 Lung Primary cancer 3,595 Tumor/Malignant -> Tumor/Malignant Enriched 5.69 2.75e-2
NSCLC_38242124__IMC__175_B2,8 Lung Primary cancer 2,386 Tumor/Malignant -> Tumor/Malignant Enriched 4.03 1.08e-2
NSCLC_38242124__IMC__175_B2,9 Lung Primary cancer 4,016 Tumor/Malignant -> Tumor/Malignant Enriched 5.04 1.03e-2
NSCLC_38242124__IMC__175_B3,1 Lung Primary cancer 3,874 Tumor/Malignant -> Tumor/Malignant Enriched 5.08 1.03e-2
NSCLC_38242124__IMC__175_B3,10 Lung Primary cancer 1,896 Tumor/Malignant -> Tumor/Malignant Enriched 3.19 1.38e-2
NSCLC_38242124__IMC__175_B3,11 Lung Primary cancer 2,889 Tumor/Malignant -> Tumor/Malignant Enriched 5.35 3.09e-2
NSCLC_38242124__IMC__175_B3,12 Lung Primary cancer 4,330 Tumor/Malignant -> Tumor/Malignant Enriched 5.56 1.08e-2
NSCLC_38242124__IMC__175_B3,13 Lung Primary cancer 912 Tumor/Malignant -> Tumor/Malignant Enriched 5.05 2.48e-2
NSCLC_38242124__IMC__175_B3,15 Lung Primary cancer 2,727 Stromal -> Stromal Enriched 3.38 1.90e-2
NSCLC_38242124__IMC__175_B3,16 Lung Primary cancer 4,456 Myeloid -> Myeloid Enriched 4.44 1.08e-2
NSCLC_38242124__IMC__175_B3,17 Lung Primary cancer 2,318 Tumor/Malignant -> Tumor/Malignant Enriched 4.30 1.55e-2
NSCLC_38242124__IMC__175_B3,2 Lung Primary cancer 3,084 Tumor/Malignant -> Tumor/Malignant Enriched 3.66 1.55e-2
NSCLC_38242124__IMC__175_B3,3 Lung Primary cancer 4,329 Tumor/Malignant -> Tumor/Malignant Enriched 5.51 1.90e-2
NSCLC_38242124__IMC__175_B3,4 Lung Primary cancer 1,576 Tumor/Malignant -> Tumor/Malignant Enriched 4.70 1.38e-2
NSCLC_38242124__IMC__175_B3,5 Lung Primary cancer 3,081 Tumor/Malignant -> Tumor/Malignant Enriched 5.52 1.13e-2
NSCLC_38242124__IMC__175_B3,6 Lung Primary cancer 3,664 Tumor/Malignant -> Tumor/Malignant Enriched 4.24 1.24e-2

Interaction Propensity (Tier 3)

2,069 ready
Sample Organ Disease state Cells Strongest directed pair ?Tier 1 from-label to to-label pair with the largest departure from neutral propensity among enriched/depleted contacts. Direction Propensity FDR
NSCLC_38242124__IMC__175_B2,3 Lung Primary cancer 4,979 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 5.48 2.35e-2
NSCLC_38242124__IMC__175_B2,4 Lung Primary cancer 3,269 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 5.29 2.21e-2
NSCLC_38242124__IMC__175_B2,5 Lung Primary cancer 3,929 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 5.43 3.96e-2
NSCLC_38242124__IMC__175_B2,6 Lung Primary cancer 3,446 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 4.36 1.71e-2
NSCLC_38242124__IMC__175_B2,7 Lung Primary cancer 3,595 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 5.69 2.10e-2
NSCLC_38242124__IMC__175_B2,8 Lung Primary cancer 2,386 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 4.03 1.35e-2
NSCLC_38242124__IMC__175_B2,9 Lung Primary cancer 4,016 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 5.04 1.67e-2
NSCLC_38242124__IMC__175_B3,1 Lung Primary cancer 3,874 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 5.08 1.86e-2
NSCLC_38242124__IMC__175_B3,10 Lung Primary cancer 1,896 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 3.19 2.04e-2
NSCLC_38242124__IMC__175_B3,11 Lung Primary cancer 2,889 Not ready NA NA NA
NSCLC_38242124__IMC__175_B3,12 Lung Primary cancer 4,330 B cell -> Tumor/Malignant cell Enriched 6.00 1.98e-2
NSCLC_38242124__IMC__175_B3,13 Lung Primary cancer 912 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 5.05 3.73e-2
NSCLC_38242124__IMC__175_B3,15 Lung Primary cancer 2,727 B cell -> Myeloid cell, unspecified Enriched 5.00 3.02e-2
NSCLC_38242124__IMC__175_B3,16 Lung Primary cancer 4,456 Granulocyte -> Granulocyte Enriched 4.77 1.35e-2
NSCLC_38242124__IMC__175_B3,17 Lung Primary cancer 2,318 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 4.30 2.64e-2
NSCLC_38242124__IMC__175_B3,2 Lung Primary cancer 3,084 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 3.66 2.35e-2
NSCLC_38242124__IMC__175_B3,3 Lung Primary cancer 4,329 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 5.51 2.31e-2
NSCLC_38242124__IMC__175_B3,4 Lung Primary cancer 1,576 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 4.70 1.87e-2
NSCLC_38242124__IMC__175_B3,5 Lung Primary cancer 3,081 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 5.52 1.58e-2
NSCLC_38242124__IMC__175_B3,6 Lung Primary cancer 3,664 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 4.24 1.76e-2